NCT03603548 is a NA clinical trial of Envarsus in Liver Transplant Rejection, sponsored by Medical University of Warsaw.

Who is sponsoring NCT03603548?

NCT03603548 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT03603548?

Interventions in NCT03603548: Envarsus, Advagraf.

What condition does NCT03603548 study?

NCT03603548 studies Liver Transplant Rejection, Immunosuppression.

Is NCT03603548 still recruiting?

NCT03603548 is currently status unknown. Last updated 27 July 2018.

Last reviewed 2018-07-27 · How we verify

NCT03603548

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Status unknown NA Last updated 27 July 2018

What this trial tests

NA trial testing Envarsus in Liver Transplant Rejection in 200 participants. Status unknown.

Timeline

9 July 2018

Primary endpoint
9 July 2023

9 July 2023

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	9 July 2018
Primary completion	9 July 2023
Estimated completion	9 July 2023
Sites	1 location across Poland

Drugs / interventions tested

Envarsus — full drug profile →
Advagraf — full drug profile →

Conditions studied

Liver Transplant Rejection — all drugs for Liver Transplant Rejection →
Immunosuppression — all drugs for Immunosuppression →

Sponsor

Medical University of Warsaw

Who can join

Adults 18 to 70, any sex, with Liver Transplant Rejection or Immunosuppression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adult patients after liver transplantation initially treated with traditional Tacrolimus variant- Prograf, switched on day 10 after orthotropic liver transplantation (OLTx) on prolonged released Tacrolimus variant in 1:1 ratio ( Advagraf vs. Envarsus)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Envarsus

Trials testing the same drug.

NCT05655273 — Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients · Phase 4 · enrolling by invitation
NCT04973982 — ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT · NA · withdrawn
NCT03823768 — Envarsus Neurotoxicity Burden in Liver Transplant Patients · Phase 4 · completed
NCT03703154 — Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Rel · completed
NCT03461445 — Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients · Phase 4 · completed

Other recruiting trials for Liver Transplant Rejection

Currently open trials in the same condition.

NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting
NCT06400771 — Safety of DNP007 in Healthy Subjects · Phase 1 · recruiting
NCT05325073 — Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients · Phase 4 · active not recruiting
NCT06153641 — Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients · active not recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03603548 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 27 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03603548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing